Assessing when to initiate anticoagulation in atrial fibrillation is not improved by including gender, says the ESC in their ...

In the first large trial of its kind, the anti-clotting medication rivaroxaban did not lower the risk of cognitive decline ...

Just 15% of patients have their filters taken out despite clear recommendations they should be removed as soon as feasible.

Cadrenal Therapeutics, Inc. is a biopharmaceutical company focused on developing tecarfarin, a clinical-stage ... ongoing research and anticoagulation best practice guidelines." ...

According to NASS, the Clinical Guidelines were based on a strict analytical process which included a strength of the ...

Through participation in the Corporate Council, Cadrenal Therapeutics will collaborate with the AC Forum as it works to identify and address unmet clinical needs, share cutting-edge research ...

“Our findings do not support the guideline recommended ... start of DOACs (within 4 days) in clinical practice.” Werring pointed out that starting anticoagulation early also had important ...

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

"This finding came as a surprise, especially in light of the safety guidelines released by the FDA in 2010 and again in 2014, ...

Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...

A new study published in the journal of Molecular Psychiatry found that heparin medication was linked to a delayed diagnosis ...

People with atrial fibrillation (AF) who have a stroke could benefit from blood thinning treatments, known as anticoagulants, ...